Volume Alert - CSX 35.45 CSX Corp $CSX Hit a high today of

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - CSX 35.45 CSX Corp $CSX Hit a high today of 35.58 Closing the day 11/07/14 at 35.45 +0.32 +0.91% With a day low of 35.22 and a total volume of 11,893,308.

CSX Recent Posts: http://investorshangout.com/CSX-Corp-CSX-50640/

CSX CSX Corp Recent Headline News

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 23.13 (+0.19), KMI: 38.75 (+0.22), HK: 3.24 (+0.34), KSS: 57.22 (+0.41), GE: 26.41 (+0.05), LMT: 186.15 (-3.73), AVAV: 29.81 (-0.65), WMT: 78.77 (+0.96), SNE: 19.62 (-0.08), M: 59.88 (+0.84), SDRL: 21.77 (+0.06), T: 34.91 (+0.19), W: 26.01 (+0.31), OPK: 8.32 (-0.10), QCOM: 69.26 (-1.32), TWTR: 40.31 (-0.53), EPR: 56.61 (+0.23), AAPL: 109.01 (+0.31), HSIC: 128.84 (-1.47), CSCO: 25.33 (+0.07), WFM: 46.81 (+1.96), CY: 10.08 (-0.02), MU: 33.01 (-0.34), SWKS: 59.88 (-2.26), IRM: 38.05 (+1.58), BAC: 17.36 (unch), MO: 49.87 (+0.31), CSX: 35.45 (+0.32), WWAV: 36.93 (-0.53), GILD: 106.45 (-0.49), TXN: 50.90 (unch), BPL: 79.30 (+1.86), JCP: 7.82 (+0.34), JWN: 73.43 (-0.25), BABA: 114.56 (+2.99)

Next Resistance Level for CSX (CSX) is $35.60
Comtex SmarTrend(R) - Fri Nov 07, 10:39AM CST
Shares of CSX (NYSE:CSX) opened today above their pivot of $35.00 and have already reached the first level of resistance at $35.36. Investors may be interested in a cross of the next upside pivot targets of $35.60 and $36.19.
CSX: 35.45 (+0.32)

CSX Concludes Racketeering and Fraud Litigation Against Asbestos Lawyers
PR Newswire - Thu Nov 06, 11:42AM CST
CSX Transportation today announced that it has resolved the final stages of its racketeering and fraud lawsuit against asbestos attorneys Robert N. Peirce Jr. and Louis A. Raimond, and radiologist Dr. Ray Harron. As part of the settlement, the West Virginia jury's verdict stands and CSX will be paid $7.3 million to satisfy the trial court judgment entered against the lawyers and doctor on September 25, 2013, and in resolution of disputed motions for attorney fees and costs.
CSX: 35.45 (+0.32)

CSX Names Kellen Riley South Carolina Industrial Development Manager
PR Newswire - Wed Nov 05, 12:00PM CST
CSX (NYSE: CSX) today announced the appointment of Kellen Riley as its South Carolina Industrial Development Manager. In this role, Riley will be responsible for managing existing customer partnerships, helping to locate rail-served industries along the CSX network in South Carolina and identifying new development sites throughout the state.
CSX: 35.45 (+0.32)

CSX Corporation Chief Financial Officer to Address Baird's 2014 Industrial Conference
PR Newswire - Wed Nov 05, 9:00AM CST
Fredrik Eliasson, CSX Corporation (NYSE: CSX) executive vice president and chief financial officer, will address Baird's 2014 Industrial Conference in Chicago, Wednesday, November 12, at 8:00 a.m. Central time / 9:00 a.m. Eastern time.
CSX: 35.45 (+0.32)

Watch for CSX to Potentially Rebound After Falling 2.18% Yesterday
Comtex SmarTrend(R) - Tue Nov 04, 3:55PM CST
CSX (NYSE:CSX) traded in a range yesterday that spanned from a low of $34.58 to a high of $35.28. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $35.02 on volume of 17.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CSX: 35.45 (+0.32)

CSX Falls 2.18% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Nov 04, 3:55PM CST
CSX (NYSE:CSX) traded in a range yesterday that spanned from a low of $34.58 to a high of $35.28. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $35.02 on volume of 17.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CSX: 35.45 (+0.32)

Federal Highway Administration Approves Construction Alternative for CSX's Virginia Avenue Tunnel Project
PR Newswire - Tue Nov 04, 3:39PM CST
The Federal Highway Administration has approved a preferred construction alternative for CSX's Virginia Avenue Tunnel project, enabling CSX to complete the tunnel's design and initiate the construction permitting process. The decision marks the completion of an extensive environmental review of the project conducted jointly with the District of Columbia Department of Transportation, which incorporates three years of input from residents, businesses and government agencies in the southeast Washington, D.C., neighborhood around the tunnel.
CSX: 35.45 (+0.32)

CSX (CSX) Crosses Pivot Point Support at $35.04
Comtex SmarTrend(R) - Tue Nov 04, 10:12AM CST
CSX (NYSE:CSX) has opened bearishly below the pivot of $35.39 today and has reached the first level of support at $35.04. Investors may be interested in a cross of the next downside pivot targets of $34.70 and $34.01.
CSX: 35.45 (+0.32)

Financial Results, Facility Opening, and Management Changes - Research Reports on Norfolk, Cardinal, CSX, Viacom and Carnival
PR Newswire - Tue Nov 04, 8:10AM CST
Today, Analysts Review released its research reports regarding Norfolk Southern Corp. (NYSE: NSC), Cardinal Health Inc. (NYSE: CAH), CSX Corporation (NYSE: CSX), Viacom, Inc. (NASDAQ: VIAB) and Carnival Corporation (NYSE: CCL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7672-100free.
NSC: 112.86 (+2.14), CCL: 40.40 (-0.17), CAH: 78.27 (-1.33), CSX: 35.45 (+0.32), VIAB: 70.63 (-0.16)

CSX Corp. Once Again Tops List of Florida's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking
Marketwired - Tue Nov 04, 5:15AM CST
CSX Corp. claims six top-ranked positions in the 2015 All-America Executive Team survey, Institutional Investor's annual poll of investors and sell-side analysts regarding America's top executives, IR professionals and IR programs.
CSX: 35.45 (+0.32)

Green Signal for 3 Transportation Stocks this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:11AM CDT
The transportation sector is stepping on the gas to zoom ahead of other sectors this earnings season.
AAWW: 41.69 (+0.79), TK: 54.90 (+1.44), FLY: 12.76 (+0.02), CNI: 69.59 (+0.32), KSU: 123.32 (-0.41), JBLU: 12.56 (-0.25), CP: 206.47 (+0.78), CSX: 35.45 (+0.32), UPS: 108.33 (+0.04), UAL: 54.18 (-1.48)

C.H. Robinson Tops on Q3 Earnings, Revenues Miss Slightly - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:30PM CDT
C.H. Robinson (CHRW) reported higher than expected earnings in the quarter.
ECHO: 27.33 (-0.21), CHRW: 71.46 (-0.14), KSU: 123.32 (-0.41), CSX: 35.45 (+0.32)

Stock Market News for October 29, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:10AM CDT
Benchmarks advanced significantly on Tuesday, banking on positive earnings results and upbeat consumer confidence data
KSS: 57.22 (+0.41), HON: 96.77 (+0.06), PFE: 29.92 (-0.12), HAL: 53.86 (+0.69), AMGN: 160.25 (-0.10), XOM: 96.59 (+0.33), CSX: 35.45 (+0.32), AET: 82.29 (-2.41), SLB: 98.73 (+1.75), COH: 33.66 (+0.20), CMI: 146.04 (-0.60), CHK: 23.41 (+0.65), EOG: 99.55 (+0.58), TWTR: 40.31 (-0.53), CVX: 118.80 (+0.27), AN: 57.59 (-0.26)

Transport ETFs Drive Up on Robust Q3 Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Tue Oct 28, 2:00PM CDT
Transport ETFs surged in double digits on inspiring Q3 earnings results.
XTN: 101.41 (-0.20), DAL: 42.69 (-0.21), KSU: 123.32 (-0.41), DIA: 175.58 (+0.29), XLI: 56.11 (+0.08), CSX: 35.45 (+0.32), IYT: 160.32 (-0.06), UNP: 118.75 (-0.19), UPS: 108.33 (+0.04), UAL: 54.18 (-1.48)

Canadian Pacific Question: To Merge Or Not To Merge?
at Investor's Business Daily - Fri Oct 24, 4:41PM CDT
These days, Canadian Pacific Railway is encountering the same sort of dilemma that all public companies must face, whether they have proven to be successes, failures or middle-of-the-road entities. Since merger-mania began sweeping through U.S....
CSX: 35.45 (+0.32)

5 Things Norfolk Southern Corp.'s Management Wants You to Know
Dan Caplinger, The Motley Fool - Motley Fool - Fri Oct 24, 2:30PM CDT
Source: Norfolk Southern. The railroad industry has been reasonably strong lately, and Norfolk Southern Corp.  weighed in with impressive earnings a few days ago that included record levels of revenue and net income for the company's third...
NSC: 112.86 (+2.14), CP: 206.47 (+0.78), CSX: 35.45 (+0.32)

CSX's Michael Ward Explains How Railroads Drive the Global Economy
at The Street - Fri Oct 24, 8:00AM CDT
CSX sees continued expansion in the U.S. economy and says it's well-positioned to 'keep moving the goods that American consumers and businesses demand.'
TSLA: 240.20 (-1.02), NSC: 112.86 (+2.14), DNKN: 47.04 (-0.01), JCP: 7.82 (+0.34), WMT: 78.77 (+0.96), MCD: 95.10 (+0.44), CP: 206.47 (+0.78), CSX: 35.45 (+0.32)

CSX Corp. (CSX) Stock Research Links

CSX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading